Bal Pharma Dividends and Buybacks
Dividend criteria checks 4/6
Bal Pharma is a dividend paying company with a current yield of 1.02% that is well covered by earnings.
Key information
1.0%
Dividend yield
-0.7%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | n/a |
| Dividend Growth | -9.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹1.200 |
| Payout ratio | 25% |
Recent dividend and buyback updates
Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20
Aug 31
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year
Aug 15Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet
Sep 19Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20
Aug 31Bal Pharma Limited's (NSE:BALPHARMA) Share Price Boosted 25% But Its Business Prospects Need A Lift Too
Aug 27Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year
Aug 15Insufficient Growth At Bal Pharma Limited (NSE:BALPHARMA) Hampers Share Price
May 30Does Bal Pharma (NSE:BALPHARMA) Have A Healthy Balance Sheet?
Mar 14Bal Pharma Limited's (NSE:BALPHARMA) 26% Share Price Surge Not Quite Adding Up
Feb 01Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 18Bal Pharma (NSE:BALPHARMA) Is Due To Pay A Dividend Of ₹1.00
Aug 28Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00
Aug 14Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00
Aug 17Bal Pharma (NSE:BALPHARMA) Has Announced A Dividend Of ₹1.00
Jul 31Is Bal Pharma (NSE:BALPHARMA) Using Too Much Debt?
Mar 08Bal Pharma (NSE:BALPHARMA) Use Of Debt Could Be Considered Risky
Nov 23Does Bal Pharma Limited (NSE:BALPHARMA) Have A Place In Your Dividend Stock Portfolio?
Aug 10
Should You Buy Bal Pharma Limited (NSE:BALPHARMA) For Its 2.3% Dividend?
Aug 10Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BALPHARMA's dividend payments have been volatile in the past 10 years.
Growing Dividend: BALPHARMA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Bal Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BALPHARMA) | 1.0% |
| Market Bottom 25% (IN) | 0.2% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (BALPHARMA) (up to 3 years) | n/a |
Notable Dividend: BALPHARMA's dividend (1.02%) is higher than the bottom 25% of dividend payers in the Indian market (0.24%).
High Dividend: BALPHARMA's dividend (1.02%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (25.3%), BALPHARMA's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (14.3%), BALPHARMA's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 01:51 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bal Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|